Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

<p><b>Background:</b> Infants in the UK were first offered a pneumococcal conjugate vaccine (PCV7) in 2006, given at 2 and 4 months of age and a booster dose at 13 months (2 + 1 schedule). A 13-valent vaccine (PCV13) replaced PCV7 in 2010. We aimed to compare the post-booster anti...

Full description

Bibliographic Details
Main Authors: Goldblatt, D, Southern, J, Andrews, N, Burbidge, P, Partington, J, Roalfe, L, Valente Pinto, M, Thalasselis, V, Plested, E, Richardson, H, Snape, M, Miller, E
Format: Journal article
Language:English
Published: Lancet 2017